| Age/Sex |
Site |
type |
TNM |
Hist. |
Nod. |
Ope |
Hep. |
RFA |
HAI. |
Phase |
Prog.(M) |
| 67/M |
L |
3 |
T4aN0 |
tub2 |
1 |
D.R2 |
P |
- |
- |
sync. |
13D. |
| 70/F |
L |
2 |
T2N3a |
tub1 |
1 |
D.D2,R2 |
P |
- |
- |
sync. |
5D. |
| 43/M |
UE |
3 |
T3N3aP1 |
por |
2:S2,3 |
T+S,D1 R2 |
S |
- |
+ |
sync. |
6D. |
| 58/M |
ULE |
4 |
T4bN3b M1LYM |
por |
1 |
T+S.D1 R2 |
P |
- |
- |
sync |
15D.H.,N |
| 67/F |
U |
2 |
T3N1 |
tub2 |
1:S5 |
T.D2,R2 |
P |
- |
+ |
sync. |
11D. H. |
| 58/F |
L |
2 |
T4aN3b M1LYM |
tub2 |
1:S6 |
D.D1,R2 |
P |
- |
- |
sync. |
8D. N. |
| 56/M |
MU |
2 |
T4aN1 |
tub1 |
1:S6 |
T.D3,R0 |
P |
- |
- |
meta.15M |
173A. |
| 79/F |
MLU |
2 |
T4aN3a |
pap |
1:S6 |
D,D2,R0 |
P |
- |
- |
sync. |
29D.N.,H |
| 60/M |
LD |
3 |
T4bN2 |
pap |
2:S3,4 |
D,D2,R2 Colon |
L |
- |
+ |
sync* |
19D H, bone |
| 55/M |
UE |
2 |
T4aN2 |
tub2 |
2:S4,7 |
T+S.D2 R2 |
P:S7 |
S4 |
- TAE |
sync. |
42D.H.,L. |
| 66/M |
M |
2 |
T3N2 |
por1 |
3:S3,6,7 |
D,D2,R2 |
P:S3 |
S6,7 |
+ |
sync. |
43D, H. |
| 54/M |
UE |
2 |
T4bN0 |
tub1 |
1:S7 1:S6 |
T.D3,R2 |
P P |
- - |
+ - |
sync. meta.24M |
34D.H.,L. |
| 61/F |
L |
5 |
T3N2 |
por |
2:S3,4 |
D.D2,R0 |
S:S3 |
S4 |
- |
meta.9M |
72D.Ac. |
| 70/M |
L |
3 |
T4aN0 |
tub1 |
1:S2 |
D,D2,R0 |
S |
- |
- |
meta.12M |
86A. |
| 71/M |
MU |
2 |
T4aN0 |
tub2 |
1 |
T,D2,R0 |
S |
- |
- |
meta.4M |
42A. |
| 74/M |
MLU |
2 |
T4aN2 |
tub2 |
1:S8 |
D,D2,R0 |
P |
- |
- |
sync. |
13D. bone |
| 78/F |
LM |
2 |
T4aN2 |
por1 |
1:S6 |
D,D2,R0 |
P |
- |
- |
meta.10M |
24D. L |
M male, F female, L lower third portion, M middle third portion, U upper third portion, T depth of tumor invasion, N lymph node metastasis, M distant metastasis, M1LYM distant lymph node metastasis, P peritoneal metastasis, Hist histology, pap papillary adenocarcinoma, por1 poorly differentiated adenocarcinoma solid type, por2 poorly differentiated adenocarcinoma non-solid type, tub1 tubular adeno carcinoma well-differentiated, tub2 tubular adenocarcinoma moderately differentiated, Nod the number of metastatic nodule, Ope operation, D distal gastrectomy, T total gastrectomy, S splenectomy, Hepa hepatectomy, P partial resection of the liver, S segmental resection of the liver, L lobectomy of the liver, RFA radiofrequency ablation, HAI hepatic arterial infusion, TAE transcatheter arterial embolization, sync synchronous, meta metachronous, Prog prognosis, M month, D dead, A alive, H recurrence in the liver, L recurrence in the lung, N recurrence in the lymph node, Ac accidental death, * patient underwent hepatectomy after gastrectomy and HAI |
